Catalogo dei prodotti della ricerca

TUBARO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.762
EU - Europa 5.498
AS - Asia 4.533
AF - Africa 474
SA - Sud America 245
OC - Oceania 124
Continente sconosciuto - Info sul continente non disponibili 6
Totale 27.642
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.470
IT - Italia 2.212
IN - India 1.175
SG - Singapore 1.174
SE - Svezia 833
CN - Cina 714
UA - Ucraina 592
FI - Finlandia 448
GB - Regno Unito 328
DE - Germania 247
CA - Canada 214
TR - Turchia 185
IE - Irlanda 184
HK - Hong Kong 170
EG - Egitto 168
IR - Iran 167
PK - Pakistan 161
ID - Indonesia 113
SA - Arabia Saudita 103
NL - Olanda 100
AR - Argentina 98
AU - Australia 97
MY - Malesia 90
RO - Romania 82
IL - Israele 77
BR - Brasile 73
NG - Nigeria 69
MX - Messico 67
JO - Giordania 62
ES - Italia 61
FR - Francia 60
BG - Bulgaria 56
ZA - Sudafrica 50
PT - Portogallo 46
RU - Federazione Russa 46
JP - Giappone 45
TW - Taiwan 44
LY - Libia 40
BE - Belgio 37
KR - Corea 33
ET - Etiopia 30
CO - Colombia 28
SY - Repubblica araba siriana 27
TG - Togo 27
NO - Norvegia 26
LK - Sri Lanka 25
GH - Ghana 22
NZ - Nuova Zelanda 22
IQ - Iraq 21
PL - Polonia 19
GR - Grecia 18
CH - Svizzera 17
DK - Danimarca 17
VN - Vietnam 17
AE - Emirati Arabi Uniti 15
PS - Palestinian Territory 15
MW - Malawi 13
PH - Filippine 13
AT - Austria 12
HR - Croazia 12
TH - Thailandia 12
DZ - Algeria 11
LB - Libano 11
PE - Perù 11
VE - Venezuela 11
BD - Bangladesh 10
CL - Cile 10
EC - Ecuador 10
MA - Marocco 10
RS - Serbia 10
KW - Kuwait 9
QA - Qatar 9
HU - Ungheria 7
CY - Cipro 6
EU - Europa 6
LT - Lituania 6
OM - Oman 6
KZ - Kazakistan 5
PW - Palau 5
SC - Seychelles 5
SD - Sudan 5
TN - Tunisia 5
AL - Albania 4
CZ - Repubblica Ceca 4
IS - Islanda 4
KE - Kenya 4
TZ - Tanzania 4
YE - Yemen 4
BH - Bahrain 3
PA - Panama 3
RW - Ruanda 3
UG - Uganda 3
AZ - Azerbaigian 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
KH - Cambogia 2
LV - Lettonia 2
MK - Macedonia 2
NP - Nepal 2
Totale 27.619
Salva come PNG Salva come JPEG
Città #
Fairfield 2.841
Woodbridge 1.411
Ashburn 1.160
Houston 1.125
Seattle 1.106
Cambridge 938
Chandler 847
Wilmington 844
Singapore 833
Ann Arbor 627
Princeton 549
Rome 528
Beijing 508
Plano 367
Boston 335
San Paolo di Civitate 325
Santa Clara 312
Jacksonville 249
Lawrence 244
San Diego 213
Dublin 174
Millbury 157
Milan 140
Andover 135
Hong Kong 131
Helsinki 100
Norwalk 96
Federal 87
Hyderabad 87
Dearborn 74
Toronto 74
Istanbul 68
Jerusalem 60
Cairo 58
London 57
New York 56
Des Moines 55
Sofia 55
Jakarta 50
Kuala Lumpur 49
Amman 48
San Mateo 47
Falkenstein 44
Tehran 44
Jeddah 42
Riyadh 41
Boardman 40
Islamabad 39
Lahore 37
Lagos 35
Bühl 34
Cedar Knolls 32
Mannheim 32
Stockholm 32
Karachi 31
Sydney 30
Los Angeles 29
Dallas 28
Falls Church 28
Florence 28
Bengaluru 27
Delhi 27
Lomé 27
Porto 27
Buffalo 26
Johannesburg 26
Madrid 24
Southend 24
Brussels 23
Accra 22
Ankara 22
Lubbock 22
Chennai 21
Hefei 21
Mumbai 21
Ottawa 21
Bogotá 20
Chicago 20
Mexico City 20
Brisbane 19
Cuttack 19
Montreal 19
San Francisco 19
Addis Ababa 18
Manchester 18
Pescara 18
Turin 18
Bremen 17
Giza 17
Melbourne 17
Mountain View 17
Tripoli 17
Central 16
Cleveland 16
Kunming 16
Mashhad 16
Moscow 16
Padova 16
Rochester 16
Sacramento 16
Totale 18.648
Salva come PNG Salva come JPEG
Nome #
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 3.917
Neoplasia prostatica intraepiteliale di alto grado (HGPIN) e cancro della prostata: relazione tra HGPIN diffuso e rischio di tumore della prostata 551
[5ARI and PSA: open questions.] 121
The new Epstein gleason score classification significantly reduces upgrading in prostate cancer patients 119
Urology practice during the COViD-19 pandemic 118
The evolving picture of lower urinary tract symptom management 116
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 112
Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: A prospective multicenter Italian cohort study 108
The effect of gabapentin on neurogenic detrusor overactivity: a pilot study. 99
Prevention of Bone Metastases in Patients with High-risk Nonmetastatic Prostate Cancer Treated with Zoledronic Acid: Efficacy and Safety Results of the Zometa European Study (ZEUS) 99
Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project) 96
The diagnosis of benign prostatic obstruction: validation of the young academic urologist clinical nomogram 95
SARS-CoV-2 vaccination modelling for safe surgery to save lives. Data from an international prospective cohort study 94
Metabolic syndrome is associated with high grade gleason score when prostate cancer is diagnosed on biopsy. 93
Low prostate concentration of lycopene is associated with development of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia. 93
null 92
Analysis of outcome after thermotherapy using different classifications of bladder outlet obstruction 91
Salvage Laparoscopic Radical Prostatectomy Following High-intensity Focused Ultrasound for Treatment of Prostate Cancer 91
Managing lines of therapy in castration-resistant prostate cancer: real-life snapshot from a multicenter cohort 89
BPH treatment: A paradigm shift 87
Metabolic syndrome and smoking are associated with persistence of nocturia after transurethral resection of the prostate 86
Translating overactive bladder questionnaires in 14 languages 85
Motor and sensory responses after percutaneous tibial nerve stimulation in multiple sclerosis patients with lower urinary tract symptoms treated in daily practice 85
A European Multicenter Randomized Noninferiority Trial Comparing 180 W GreenLight-XPS Laser Vaporization and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: 12-Month Results of the GOLIATH Study. 85
Reduction of Prostate-specific Antigen After Tamsulosin Treatment in Patients With Elevated Prostate-specific Antigen and Lower Urinary Tract Symptoms Associated With Low Incidence of Prostate Cancer at Biopsy 84
A probability based system for combining simple office parameters as a predictor of bladder outflow obstruction. 84
null 84
Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences? 84
null 83
CHANGES IN PRESSURE-FLOW PARAMETERS IN PATIENTS TREATED WITH TRANSURETHRAL MICROWAVE THERMOTHERAPY 83
null 83
null 82
Finasteride for prostatic disease: an updated and comprehensive review 81
Serum level of chromogranin are not predictive of high grade poorly differentiated prostate cancer: results from an italian biopsy cohort 80
Italian validation of the urogenital distress inventory and its application in LUTS patients 80
Role of abdominal obesity for functional outcomes and complications in men treated with radical prostatectomy for prostate cancer: results of the Multicenter Italian Report on Radical Prostatectomy (MIRROR) study 80
Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction 80
Dutasteride add-on therapy reduces detrusor mass in patients with benign prostatic enlargement not satisfied with alpha-adrenergic antagonist monotherapy. A single center prospective study 79
Metabolic Syndrome Does Not Increase the Risk of Ejaculatory Dysfunction in Patients With Lower Urinary Tract Symptoms and Benign Prostatic Enlargement. An Italian Single-center Cohort Study 79
Measurement of post-void residual urine. 78
Metabolic syndrome and lower urinary tract symptoms: the role of inflammation 78
Trends in the use of partial nephrectomy for cT1 renal tumors. analysis of a 10-yr european multicenter dataset 78
Adolescence transitional care in neurogenic detrusor overactivity and the use of OnabotulinumtoxinA: a clinical algorithm from an Italian consensus statement 78
Physical activity as a risk factor for prostate cancer diagnosis. a prospective biopsy cohort analysis 77
L'EFFETTO DEL GLUCACONE E DELL'IPERDIURESI NEL TRATTAMENTO DELLA CALCOLOSI URETERALE 77
Re: See W, Iversen P, Wirth M, McLeod D, Garside L, Morris T. Immediate treatment with bicalutamide 150 mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostatic cancer. Eur Urol 2003;44:512-8. 77
Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study. 77
Tolterodine extended release in the treatment of male oab/storage luts: a systematic review. 77
The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy 76
Combination therapies for improved management of lower urinary tract symptoms/benign prostatic hyperplasia 76
Autophagy deactivation is associated with severe prostatic inflammation in patients with lower urinary tract symptoms and benign prostatic hyperplasia 76
Impact of fesoterodine on quality of life: pooled data from two randomized trials 76
Synchronous urinary tract metastases from breast cancer 75
Quality of life after prostate cancer diagnosis: data from the pros-IT CNR 75
Effect of vacation on urinary symptoms in healthcare workers. An Italian multicenter study 75
Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence 74
Treatment of detrusor overactivity of neurogenic origin by tamsulosin treatment: a pilot study. 73
Metabolic syndrome, obesity, and radical cystectomy complications: a clavien classification system-based analysis 73
Plication corporoplasty versus Nesbit operation for the correction of congenital penile curvature. A long-term follow-up 73
Urodynamic obstruction in women with stress urinary incontinence--do nonintubated uroflowmetry and symptoms aid diagnosis? 73
Investigation of benign prostatic hyperplasia 72
Re: Safety and Feasibility of the Prostatic Urethral Lift: A Novel, Minimally Invasive Treatment for Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH). 72
Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study. 72
Acute urinary retention increases the risk of complications after transurethral resection of the prostate: a population-based study. 72
180-W XPS greenlight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial - The GOLIATH study 72
The use of voiding studies (flowmetry and urodynamics) in the assessment and follow-up of patients. 71
Transurethral needle ablation of the prostate 71
Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise 71
Female pelvic congenital malformations. Part I: embryology, anatomy and surgical treatment. 71
Benign prostatic hyperplasia: A progressive disease of aging men 70
null 70
Needle biopsy size and pathological Gleason Score diagnosis: No evidence for a link 70
Development and validation of patient-reported outcomes measures for overactive bladder: A review of concepts 70
A preliminary study of micro-RNAs as minimally invasive biomarkers for the diagnosis of prostate cancer patients 70
Defining overactive bladder: Epidemiology and burden of disease 69
Pelvic organ prolapse and overactive bladder 69
The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS 69
The influence of family history on prostate cancer risk: implications for clinical management. 69
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients. the Pros-IT CNR study 69
Pros-IT CNR: an Italian prostate cancer monitoring project 69
Adverse events related to abiraterone and enzalutamide treatment. analysis of the EudraVigilance database and meta-analysis of registrational phase III studies 69
Smoking reduces PSA accuracy for detection of prostate cancer. Results from an Italian cross-sectional study 69
GreenLight Photoselective Vaporization of the Prostate. One Laser for Different Prostate Sizes 69
Inflammatory mediators in the development and progression of benign prostatic hyperplasia 69
The diagnosis of bladder outlet obstruction in men by ultrasound measurement of bladder wall thickness 68
Ultrasound Estimated Bladder Weight and Measurement of Bladder Wall Thickness-Useful Noninvasive Methods for Assessing the Lower Urinary Tract? 68
The impact of lower urinary tract symptoms on male sexual health: EpiLUTS 68
null 68
VALIDATION OF THE COBRA NOMOGRAM FOR THE PREDICTION OF CANCER SPECIFIC SURVIVAL IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY 68
Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort Study. 68
Clinical Implications for the Early Treatment of Benign Prostatic Enlargement (BPE). a Systematic Review 68
Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer. a single biopsy cohort analysis 68
The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study 68
Continuous intra-arterial administration of recombinant interleukin-2 in low-stage bladder cancer: a phase IB study. 67
Overactive bladder: epidemiology and social impact 67
Prostate biopsy quality is independent of needle size: A randomized single-center prospective study 67
When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of a novel risk stratification tool 67
Position: Prone or Supine Is the Issue of Percutaneous Nephrolithotomy 67
Visual assessment of uroflowmetry curves: Description and interpretation by urodynamists 67
TRANSURETHRAL MICROWAVE THERMOTHERAPY IN THE TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA 66
Totale 12.204
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.047
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.047
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.529 0 0 0 0 0 582 703 640 563 450 475 116
2020/20212.436 194 194 94 158 479 157 77 265 252 228 255 83
2021/20224.778 92 259 441 213 607 218 144 492 403 334 591 984
2022/20234.277 1.039 810 164 342 419 356 156 223 430 70 191 77
2023/20245.933 488 634 416 529 603 767 729 859 52 302 238 316
2024/20251.932 210 297 396 232 515 282 0 0 0 0 0 0
Totale 28.804